![Scott Koenig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Koenig
Gründer bei
MACROGENICS, INC.
Vermögen: 6 Mio $ am 31.05.2026
Profil
Scott E.
Koenig is the founder of MacroGenics, Inc., founded in 2000, where the title held is Director starting in 2025.
Current jobs include Director at Biotechnology Innovation Organization, Director at International Biomedical Research Alliance, and Member at Cornell University Council.
Former jobs include Chairman at Children's Research Institute, Inc., Chairman at Beacon Therapeutics (USA), Inc. from 2004 to 2022, Director at Children's National Hospital (District of Columbia), Independent Director at GlycoMimetics, Inc. from 2017 to 2025, Member-Life Sciences Advisory Board at Cornell University, Principal at National Institutes of Health, Principal at National Institute of Allergy & Infectious Diseases from 1984 to 1990, and Senior Vice President-Research at MedImmune LLC.
Education includes undergraduate and doctorate degrees from Cornell University and a doctorate degree from The University of Texas Health Science Center at Houston.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MACROGENICS, INC. 2,3 % | 19.05.2026 | 1.462.502 ( 2,3 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Scott Koenig
| Unternehmen | Position | Beginn |
|---|---|---|
| MACROGENICS, INC. | Gründer | 14.08.2000 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Direktor/Vorstandsmitglied | - |
Cornell University Council | Corporate Officer/Principal | - |
International Biomedical Research Alliance
 International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services Provides doctoral training program for science students committed to biomedical research careers | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Scott Koenig
| Unternehmen | Position | Ende |
|---|---|---|
GlycoMimetics, Inc.
 GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Direktor/Vorstandsmitglied | 21.02.2025 |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Vorsitzender | 30.11.2022 |
National Institute of Allergy & Infectious Diseases
 National Institute of Allergy & Infectious Diseases General GovernmentGovernment Operates as an agency of the United States department of health and human services | Corporate Officer/Principal | - |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | - |
Children's National Hospital (District of Columbia)
 Children's National Hospital (District of Columbia) Hospital/Nursing ManagementHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | - |
Ausbildung von Scott Koenig
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
57
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoMimetics, Inc.
GlycoMimetics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat inflammatory diseases and cancer | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Children's National Hospital (District of Columbia)
Children's National Hospital (District of Columbia) Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
International Biomedical Research Alliance
International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services Provides doctoral training program for science students committed to biomedical research careers | Commercial Services |
National Institute of Allergy & Infectious Diseases
National Institute of Allergy & Infectious Diseases General GovernmentGovernment Operates as an agency of the United States department of health and human services | Government |
Children's Research Institute, Inc. | |
Cornell University Council | |
The University of Texas Health Science Center at Houston
 The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
